Foley & Lardner LLP recently represented New Enterprise Associates, Inc. as lead investor. Comanche Biopharma closed its $75 million Series B financing. New Enterprise Associates, Inc. acted…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
